2016
DOI: 10.1111/bjd.14803
|View full text |Cite
|
Sign up to set email alerts
|

Shared decision making and patient decision aids in dermatology

Abstract: Shared decision making combines individual patient interests and values with clinical best evidence under the guiding principle of patient autonomy. Patient decision aids can support shared decision making and facilitate decisions that have multiple options with varying outcomes for which patients may attribute different values. Given the variable psychosocial impact of skin disease on individuals and relative uncertainty regarding best treatments and their adherence in many dermatological conditions, informed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
44
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(44 citation statements)
references
References 13 publications
0
44
0
Order By: Relevance
“…A recent comparison of dermatologist and patient preferences has highlighted the potential for improved patient care following better communication between these groups . There may be an important role to play for shared decision making and the use of patient decision aids in the context of dermatology …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A recent comparison of dermatologist and patient preferences has highlighted the potential for improved patient care following better communication between these groups . There may be an important role to play for shared decision making and the use of patient decision aids in the context of dermatology …”
Section: Discussionmentioning
confidence: 99%
“…32 There may be an important role to play for shared decision making and the use of patient decision aids in the context of dermatology. 33 The importance of understanding the drivers of treatment choice is emphasized by the increasing complexity for clinicians and patients in selecting a first-line biologic, with a larger number of candidate drugs becoming available. Two IL-17 inhibitors (secukinumab and ixekizumab) have recently been recommended by NICE for treating moderate-to-severe plaque psoriasis.…”
Section: Discussionmentioning
confidence: 99%
“…This must take into consideration personal disease history, severity and co-morbidities, and match realistic care expectations and personal preferences to the best scientific evidence available. Shared decision making can be supported by patient decision aids [ 19 ].…”
Section: Main Textmentioning
confidence: 99%
“…Health care providers are experts in the treatment and management of the conditions of their patients. These are the precepts of SDM-by acknowledging these fundamental principles, SDM presents an actionable framework, whereby patients and providers co-create effective solution strategies to complex issues [17].…”
Section: Improving Value Through Sdmmentioning
confidence: 99%